Announcements Trials
Browse Landscape

Phase

Phase 1 34Phase 1/2 11Phase 2 9Phase NA 6Phase 3 3Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 18Thoracic 1Sarcoma 1Other solid neoplasm 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 182Triple Negative Breast Neoplasms 24Lung Neoplasms 16Ovarian Neoplasms 11Melanoma 11Prostatic Neoplasms 10Pancreatic Neoplasms 10Colonic Neoplasms 10Sarcoma 9Neoplasms 8Stomach Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Head and Neck Neoplasms 6Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Renal Cell 5Breast Neoplasms, Male 5Uterine Cervical Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Brain Neoplasms 4Small Cell Lung Carcinoma 3Liver Neoplasms 3Kidney Neoplasms 3Endometrial Neoplasms 3Carcinoma, Lobular 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Fallopian Tube Neoplasms × Breast × Clear all
NCT05368506 2023-05-06

ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡